Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:SubstanceBox/Psilocybin mushrooms: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older edit
>Unity
WiP
>Isaak
Better adjust durations based on "drug high" graph in linked study
 
(25 intermediate revisions by 8 users not shown)
Line 19: Line 19:
     |PhotoImageCaption=
     |PhotoImageCaption=


     <!-- Combination -->chispera
     <!-- Combination -->
     |CombinationImage1_Caption=
     |CombinationImage1_Caption=
     |CombinationImage1_File=
     |CombinationImage1_File=
Line 33: Line 33:


     <!-- Structure -->
     <!-- Structure -->
     |MolecularStructureCaption=Molecular structure of 4-PO-DMT.
     |MolecularStructureCaption=Molecular structure of psilocybin.
     |SkeletalImageFile=File:4-PO-DMT.png
     |SkeletalImageFile=File:Psilocybin.svg
     |SkeletalImageWidth=245px
     |SkeletalImageWidth=245px
     |3DImageFile=File:shrooms.png
     |3DImageFile=File:shrooms.png
     |3DImageWidth=200px
     |3DImageWidth=175px


     <!-- Nomenclature -->
     <!-- Nomenclature -->
     |NameCommon=Psilocybin, Magic Mushrooms, Shrooms, 4-PO-DMT
     |NameCommon=[[common name::Psilocybin]], [[common name::Psilocybin mushrooms]], [[common name::Magic Mushrooms]], [[common name::Shrooms]], [[common name::4-PO-DMT]]
     |NameSubstitution=4-phosphoryloxy-N,N-dimethyltryptamine
     |NameSubstitution=4-Phosphoryloxy-N,N-dimethyltryptamine
     |NameSystematic=3-[2-(dimethylamino)ethyl]-1H-indol-4-ol
     |NameSystematic=3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol


     <!-- Class Membership -->
     <!-- Class Membership -->
Line 67: Line 67:
     |SmokedROA_Aftereffects=
     |SmokedROA_Aftereffects=


    |OralROA=true
    |OralROA=true
    |OralROA_Collapsed=false
    |OralROA_Collapsed=false
    |OralROA_Caption=<br>
    |OralROA_Caption='''The dosage below assumes that one is using dried [[psilocybin mushrooms]] of the [[Psilocybe cubensis]] variety. If you are using fresh mushrooms, it is generally advised to multiply weight by ten.'''
<span style="color:black">'''The dosage below assumes that one is using dried [[psilocybin mushrooms]] and not pure psilocin as this is extremely uncommon. If you are using fresh mushrooms simply multiply weight by ten.'''</span>
    |OralROA_Bioavailability=
    |OralROA_Bioavailability=
    |OralROA_Threshold=[[Oral threshold dose::2.5]] [[Oral dose units::mg]] Psilocybin
    |OralROA_Threshold=[[Oral threshold dose::0.25]] - 0.5 [[Oral dose units::g]]
    |OralROA_Light=[[Oral min light dose::2.5]] - [[Oral max light dose::10]] mg Psilocybin
    |OralROA_Light=[[Oral min light dose::0.5]] - [[Oral max light dose::1.5]] g
    |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::25]] mg Psilocybin
    |OralROA_Common=[[Oral min common dose::1.5]] - [[Oral max common dose::3]] g
    |OralROA_Strong=[[Oral min strong dose::25]] - [[Oral max strong dose::50]] mg Psilocybin
    |OralROA_Strong=[[Oral min strong dose::3]] - [[Oral max strong dose::6]] g
    |OralROA_Heavy=[[Oral heavy dose::50]] mg Psilocybin +
    |OralROA_Heavy=[[Oral heavy dose::6]] g +  
    |OralROA_TimelineFile=
    |OralROA_TimelineFile=
    |OralROA_TimelineWidth=
    |OralROA_TimelineWidth=
    |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::8]] [[Oral total time units::hours]]
    |OralROA_Duration=[[Oral min total time::4]] - [[Oral max total time::6]] [[Oral total time units::hours]]
    |OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::45]] [[Oral onset time units::minutes]]
    |OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::45]] [[Oral onset time units::minutes]]
    |OralROA_Comeup=[[Oral min comeup time::1]] - [[Oral max comeup time::1.5]] [[Oral comeup time units::hours]]
    |OralROA_Peak=[[Oral min peak time::2]] - [[Oral max peak time::3]] [[Oral peak time units::hours]]
    |OralROA_Peak=[[Oral min peak time::2]] - [[Oral max peak time::2.5]] [[Oral peak time units::hours]] <ref>{{cite journal | vauthors=((Pablo Mallaroni)), ((Natasha L. Mason )), ((Johannes T. Reckweg)), ((Riccardo Paci)), ((Sabrina Ritscher)), ((Stefan W. Toennes)), ((Eef L. Theunissen)), ((Kim P.C. Kuypers)), ((Johannes G. Ramaekers)) | journal=Clinical Pharmacology and Therapeutics | title=Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition | date= May 2023 | url=https://doi.org/10.1002/cpt.2958 | doi=10.1002/cpt.2958}}</ref>
    |OralROA_Offset=[[Oral min offset time::1.5]] - [[Oral max offset time::2]] [[Oral offset time units::hours]]
    |OralROA_Offset=[[Oral min offset time::2.5]] - [[Oral max offset time::3.5]] [[Oral offset time units::hours]]
    |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::36]] [[Oral afterglow time units::hours]]
    |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::24]] [[Oral afterglow time units::hours]]


}}
}}

Latest revision as of 11:07, 5 August 2023

SubstanceBox/Psilocybin mushrooms
Chemical Nomenclature
Common names Psilocybin, Psilocybin mushrooms, Magic Mushrooms, Shrooms, 4-PO-DMT
Substitutive name 4-Phosphoryloxy-N,N-dimethyltryptamine
Systematic name 3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol
Class Membership
Psychoactive class Psychedelic
Chemical class Tryptamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Threshold 2.5 mg Psilocybin
Light 2.5 - 10 mg Psilocybin
Common 10 - 25 mg Psilocybin
Strong 25 - 50 mg Psilocybin
Heavy 50 mg Psilocybin +
Duration
Total 6 - 8 hours
Onset 20 - 45 minutes
Come up 1 - 1.5 hours
Peak 2 - 2.5 hours [1]
Offset 2.5 - 3.5 hours
After effects 4 - 24 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

  1. ↑ Pablo Mallaroni, Natasha L. Mason , Johannes T. Reckweg, Riccardo Paci, Sabrina Ritscher, Stefan W. Toennes, Eef L. Theunissen, Kim P.C. Kuypers, Johannes G. Ramaekers (May 2023). "Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition". Clinical Pharmacology and Therapeutics. doi:10.1002/cpt.2958. 
Retrieved from "http://psy.st/w/index.php?title=Template:SubstanceBox/Psilocybin_mushrooms&oldid=134315"